Wholesale of pharmaceutical and medical goods
TMOS PHARMA AS
Revenue 2024
NOK 1.4m
Operating profit
NOK −308,000
Equity
NOK −114,000
Incorporated
2018
Share capital
NOK 43,000
Key figures · 2024
Current ratio
0.91
Equity ratio
-9.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -21.6% | |
| Net margin (%%) | -30.4% | |
| Return on assets (%%) | -25.7% | |
| Likviditet | ||
| Current ratio | 0.91 | |
| Working capital | −114k | |
| Soliditet | ||
| Equity ratio (%%) | -9.5% | |
| Debt-to-equity ratio | -11.53 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.